BIOMARKERS OF DEVELOPING COMPLICATIONS OF INFECTIOUS MONONUCLEOSIS ASSOCIATED WITH EPSTEIN-BARR VIRUS

FIELD: medicine.SUBSTANCE: invention relates to medicine. Disclosed is use of biomarkers for evaluating the risk of developing infectious mononucleosis associated with Epstein-Barr virus, where biomarkers are genes BCL2L2, BCL2L11, CASP3, CASP7, CASP8, MAP3K14, MCL1, NFKB1 and mRNA BCL2-NM_000633, B...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Sakharnov Nikolaj Aleksandrovich, Filatova Elena Nikolaevna, Knyazev Dmitrij Igorevich, Utkin Oleg Vladimirovich, Presnyakova Nataliya Borisovna
Format:	Patent
Sprache:	eng ; rus
Schlagworte:	BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS OR TEST PAPERS THEREFOR CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL ORENZYMOLOGICAL PROCESSES ENZYMOLOGY INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEICACIDS OR MICROORGANISMS METALLURGY MICROBIOLOGY MUTATION OR GENETIC ENGINEERING PHYSICS PROCESSES OF PREPARING SUCH COMPOSITIONS SPIRITS TESTING VINEGAR WINE
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	FIELD: medicine.SUBSTANCE: invention relates to medicine. Disclosed is use of biomarkers for evaluating the risk of developing infectious mononucleosis associated with Epstein-Barr virus, where biomarkers are genes BCL2L2, BCL2L11, CASP3, CASP7, CASP8, MAP3K14, MCL1, NFKB1 and mRNA BCL2-NM_000633, BCL2L1-NM_138578, BIRC2-NM_001166, TNFRSF10D-NM_003840, TRAF2-NM_021138, RELB-NM_006509, XIAP-NM_001167.EFFECT: invention provides an effective assessment of the risk of developing complications of infectious mononucleosis associated with Epstein-Barr virus.1 cl, 5 tbl, 4 ex Изобретение относится к области медицины. Предложено применение биомаркеров для оценки риска развития осложнений инфекционного мононуклеоза, ассоциированного с вирусом Эпштейна-Барр, где биомаркеры представляют собой гены BCL2L2, BCL2L11, CASP3, CASP7, CASP8, MAP3K14, MCL1, NFKB1 и мРНК BCL2-NM_000633, BCL2L1-NM_138578, BIRC2-NM_001166, TNFRSF10D-NM_003840, TRAF2-NM_021138, RELB-NM_006509, XIAP-NM_001167. Изобретение обеспечивает эффективную оценку риска развития осложнений инфекционного мононуклеоза, ассоциированного с вирусом Эпштейна-Барр. 5 табл., 4 пр.